Clinical trials
Cervical Cancer clinical trials
Below are recruiting cervical cancer clinical trials, each written for real people, not researchers. We’re tracking 409 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05283330RecruitingPhase 1
Tested 212Pb imaging drug for certain advanced GRPR tumors
This early-phase study tests how safe and tolerable an experimental radiation drug is for adults with certain advanced or metastatic cancers that show a target called GRPR. Doctors will also use special scans to confirm the tumor has the target so the treatment can be delivered to the right place.
Chicago, IllinoisAges 18 years+ - NCT06284031Recruiting
Cervical cancer brachytherapy with needles in 3 sessions
This trial tests a special type of radiation, called brachytherapy, given in 3 sessions using thin needles. It is for people with cervical cancer that has not spread too far, and who have already had standard radiation treatment.
SingaporeAges 21 years+ - NCT05078528Recruiting
Low-cost imaging test during cervical follow-up
This study tests a low-cost imaging approach during colposcopy, for people who have abnormal cervical screening results or need follow-up after prior abnormal cells. It may help clinics detect cervical changes more easily and at lower cost.
Porto Alegre, Rio Grande do SulAges 25 years+ - NCT05406856Recruiting
Adaptive proton therapy for cervical cancer with chemo
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
LeidenAges 18 years+ - NCT04422366RecruitingPhase 3
9-valent HPV vaccine study for healthy Chinese women
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
Liuzhou, GuangxiAges 20–45 - NCT07351110Recruiting
Cervical cancer prevention for women with obesity or diabetes
This trial tests a program to help women with obesity or type 2 diabetes get cervical cancer screenings. It uses text messages or emails to remind and support you in getting screened.
Gainesville, FloridaAges 25 years+ - NCT05528237Enrolling by invitation
HPV self-test to help cervical cancer screening access
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Seattle, WashingtonAges 25 years+ - NCT07850128Recruiting
Cervical cancer risk after HPV detection
This study looks at women in the Stockholm area who tested positive for HPV (a virus linked to cervical cancer) to see if and how often cervical cancer develops. It aims to understand the risk better, which could improve screening and prevention.
StockholmAges 22–70 - NCT04859530Recruiting
Smartphone AI test for cervical cancer screening
This study checks whether a smartphone-based AI tool can help screen for cervical cancer. You may be offered the AI-assisted screening during a clinic visit to see if it works well when visualizing the cervix.
Dschang, MenouaAges 30–49 - NCT07286253RecruitingPhase 2
QL1706 plus chemo before surgery for advanced cervical cancer
This trial is testing whether adding the immunotherapy drug QL1706 to standard chemotherapy before surgery can improve outcomes for women with a certain type and stage of cervical cancer. It is for women whose cancer has not been treated yet and who are healthy enough for the treatment.
Guangzhou, GuangdongAges 18–70 - NCT07003620RecruitingPhase 2
Immunotherapy before surgery for advanced cervical cancer
This trial tests if giving immunotherapy with chemotherapy before surgery can shrink tumors in people with advanced cervical cancer. It is for those who have not had any prior treatment.
Guangzhou, GuangdongAges 18–80 - NCT04016389Recruiting
Neoadjuvant chemo then fertility-sparing surgery for cervical cancer
This study looks at whether giving chemotherapy before surgery (neoadjuvant chemotherapy) can shrink certain cervical cancers enough to allow fertility-sparing surgery. It may help some people avoid removing the uterus, while still treating the cancer effectively.
Houston, TexasAges 18–40 - NCT06082765Recruiting
Cervical cancer screening with menstrual blood test
This trial tests if a new DNA test (NGS-HPV) using menstrual blood can detect HPV and help screen for cervical cancer. You may participate if you have regular periods and plan to get cervical screening.
Wuhan, HubeiAges 20–60 - NCT06751030Recruiting
Cervical cancer screening study for HIV-positive women in Nigeria
This study offers home-based education and cervical cancer screening using a simple vaginal self-collection method. It aims to increase access to care for women living with HIV in Nigeria.
AbujaAges 25–50 - NCT05857631Recruiting
After-surgery radiation schedule for cervical or uterine cancers
This trial studies a shorter, focused radiation schedule given after surgery for certain higher-risk cervical or endometrial (uterine) cancers. It may help reduce cancer recurrence while checking side effects in the bladder and bowel area.
Navi Mumbai, MaharahstraAges 18–80 - NCT06544720RecruitingPhase 1
SCG142 TCR-T cell therapy for HPV-related cancers
This trial tests a new treatment called SCG142 TCR-T cells for cancers caused by HPV. The therapy uses your own immune cells to fight the tumor. It may help if other treatments haven't worked or are not available.
Qingdao, ShandongAges 18 years+ - NCT06128304Recruiting
Cervical cancer screening for women with HIV
This trial offers quick cervical cancer screening and treatment for women living with HIV, aiming to prevent cancer and improve health.
La Jolla, CaliforniaAges 25–64 - NCT06444815RecruitingPhase 1
Study of VET3-TGI for advanced solid tumors
This trial tests an experimental treatment called VET3-TGI, which is injected directly into tumors. It is for people with advanced solid tumors who have already tried other treatments and are looking for new options.
Los Angeles, CaliforniaAges 18 years+ - NCT05937958Recruiting
MR-guided linac boost for gynecologic cancers when brachytherapy isn’t possible
This study tests a targeted radiation “boost” delivered using an MRI-guided machine for certain gynecologic cancers when the usual treatment (brachytherapy) can’t be done. It may help improve control of the cancer while still aiming for cure.
OdenseAges 18 years+ - NCT06640283RecruitingPhase 2
Circulating tumor DNA monitoring for cervical and anal cancer
This trial uses a blood test to track tumor DNA in patients with HPV-related cervical or anal cancer. It aims to see if this test can detect early signs of recurrence after radiation therapy, helping guide follow-up care.
São PauloAges 18 years+ - NCT07177170Recruiting
Cancer screening: one visit vs. multiple visits for women with HIV
This study tests whether one or multiple clinic visits work better for cervical cancer screening in women living with HIV. It aims to see which approach is easier, more complete, and more acceptable.
FoumbanAges 25–49 - NCT05472311Recruiting
Thermal ablation rollout and cost study for cervical pre-cancer
This study looks at how best to add a treatment called thermal ablation for cervical pre-cancer into regular clinic care, and how much it costs. It may help clinics deliver care more effectively and more affordably in the future.
Thika, Kiambu CountyAges 21–60 - NCT07209917Recruiting
Cervical cancer prevention for women with HIV and HPV
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
Bangalore, KarnatakaAges 25–50 - NCT07120529Recruiting
Comparing two types of hysterectomy for early cervical cancer
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
BialystokAges 18–85
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cervical cancer?
- Yes. Clin2 currently lists 409 recruiting cervical cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cervical cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cervical cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.